Overview

NorthStar
Development

Our focus is on providing a spectrum of non-uranium based radioisotopes for use in diagnosing and treating serious diseases. State-of-the-art equipment and facilities and a robust pipeline are planned to help patients in the U.S. and around the world.

SUPPLYING THE GROWING DEMAND
FOR ESSENTIAL RADIOISOTOPES
REQUIRES

NORTHSTAR’s
MANUFACTURING

Our state-of-the-art U.S. operation provides environmentally preferred, scalable and reliable production.
WE SHARE WHAT
WE’VE LEARNED IN

RADIOPHARMA
DEVELOPMENT

NorthStar is ideally positioned to help pharmaceutical companies develop molecules that will optimally bind with a range of radioisotopes, and to ensure the binding process is efficient, reliable and repeatable.

CREATING SOLUTIONS FOR
RADIOPHARMACEUTICAL DEMAND REQUIRES A

ROBUST
PIPELINE

We are advancing a broad pipeline to ensure clinicians and patients have access to the next generation of diagnostic and therapeutic radioisotopes.

LEVERAGING ADVANCED PROCESSES THAT ARE
ECO FRIENDLY

The advanced technologies employed at NorthStar produce benign and recyclable waste streams that are free of the toxic and radioactive waste associated with uranium-based production. In this way, the radioisotopes produced at NorthStar is significantly more environmentally friendly than current standards.